Group 1 - Longte Intelligent's wholly-owned subsidiary plans to establish a private equity investment fund focusing on low-altitude economy and embodied intelligence industry chain with a total investment of 15 million RMB [1] - Huadian Technology signed significant contracts totaling approximately 5.567 billion RMB, which includes design supply and construction contracts for the Nusantara project [2] - Shanghai Xiba plans to participate in the auction for Yuyuan Rare Earth's lithium sulfide business assets to promote development in the new energy sector [3] Group 2 - Lens Technology has set the final price for its H-share issuance at 18.18 HKD per share, with expected listing on July 9, 2025 [4] - Yiling Pharmaceutical received approval for clinical trials of its new drug "G201-Na capsule," aimed at controlling ovulation in assisted reproductive technology [5] - Chendian International announced that the adjustment of the time-of-use electricity pricing mechanism will have a slight impact on its electricity business revenue, with a preliminary estimate of an increase of 382,000 RMB [6] Group 3 - Ruiskanda's chairman and general manager are under criminal coercive measures for suspected violations related to information disclosure [7] - Changhong High-Tech is planning to acquire 100% equity of Guangxi Changke New Materials Co., Ltd., with stock suspension expected for up to 10 trading days [8] Group 4 - Aerospace Engineering is expected to win a project worth 2.392 billion RMB [9] - Several companies, including Xianggang Technology and Yinglian Co., are forecasting significant increases in net profits for the first half of the year, with growth rates ranging from 185% to 478% [10]
A股公告精选 | 翔港科技(603499.SH)等多家上市公司中报业绩预喜